David Silberstein
Fortune : - $ au 31/05/2026
Fortune : - $ au 31/05/2026
David S.
Silberstein currently works at Lantern Pharma, Inc., as Independent Director from 2018, Biological Mimetics, Inc., as Director from 2016, and BioMimetix Pharmaceutical, Inc., as Chief Operating Officer from 2013.
Dr. Silberstein received his doctorate degree from The Trustees of Columbia University in The City of New York.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
LANTERN PHARMA, INC. -.--% | 17/04/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| LANTERN PHARMA INC. | Directeur/Membre du Conseil | 01/06/2018 |
BioMimetix Pharmaceutical, Inc.
BioMimetix Pharmaceutical, Inc. Miscellaneous Commercial ServicesCommercial Services Provides development services for biopharmaceutical products | Directeur des opérations | 01/01/2013 |
Biological Mimetics, Inc.
Biological Mimetics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Directeur/Membre du Conseil | 01/01/2016 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 4 |
|---|---|
The Trustees of Columbia University in The City of New York
The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BioMimetix Pharmaceutical, Inc.
BioMimetix Pharmaceutical, Inc. Miscellaneous Commercial ServicesCommercial Services Provides development services for biopharmaceutical products | Commercial Services |
Lantern Pharma, Inc.
Lantern Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops cancer drug from advanced genomics and artificial intelligence | Health Technology |
Biological Mimetics, Inc.
Biological Mimetics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national